miRNA expression prior and after AAA repair - miRNA as a potential biomarker for endoleak?

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016547

Enrollment

Registered

2019-07-03

Start date

2019-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal aortic aneurysm I71.02

Interventions

Group 1: Patients treated for infrarenal AAA will have a blood serum control on specific miRNA for AAA. Patients will be devided into 2 Groups: Group I for open repair (OR) and Group II for EVAR. Bloo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: all patients treated with infrarenal or juxtarenal AAA with open repair or EVAR

Exclusion criteria

Exclusion criteria: previous operation on the aorta coincident aneurym (thoracic aorta, visceral arteries, femoral or poplital) active malignoma PAD genetic tissue disorder underaged women that can still bare children

Design outcomes

Primary

Measure	Time frame
Expression of specific miRNA	—

Secondary

Measure	Time frame
Endoleak after EVAR after 12 months	—

Countries

Germany

Contacts

Public ContactDaphne Gray

Goethe Universität Frankfurt, Klinik für Gefäß- und Endovaskularchirurgie

daphne.gray@kgu.de061 6301 5349

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026